Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Schedule of Revenues, Operating Expenses and Operating Income (Loss) by Reportable Segment (Details)

v3.20.2
Segment Reporting - Schedule of Revenues, Operating Expenses and Operating Income (Loss) by Reportable Segment (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Net revenue $ 19,578,790 $ 16,749,499 $ 41,445,958 $ 31,829,710
Direct operating costs 12,556,674 11,396,395 26,123,404 21,243,935
Selling and marketing 1,625,045 382,557 3,206,398 743,956
General and administrative 5,392,857 5,143,754 10,985,582 9,305,830
Research and development 2,146,325 218,408 4,479,451 473,064
Depreciation and amortization 2,404,915 836,161 3,737,701 1,592,901
Impairment and unoccupied lease charges 63,175 360,826
Change in contingent consideration (64,203)
Total operating expenses 24,188,991 17,977,275 48,893,362 33,295,483
Operating income (loss) (4,610,201) (1,227,776) (7,447,404) (1,465,773)
Healthcare IT [Member]        
Net revenue 17,126,211 13,460,575 35,967,075 25,580,319
Direct operating costs 10,760,718 8,929,458 21,926,644 16,403,912
Selling and marketing 1,616,689 374,196 3,189,461 726,147
General and administrative 3,013,903 3,295,146 6,894,125 5,757,549
Research and development 2,146,325 218,408 4,479,451 473,064
Depreciation and amortization 2,325,418 757,084 3,578,708 1,435,071
Impairment and unoccupied lease charges 63,175   360,826  
Change in contingent consideration       (64,203)
Total operating expenses 19,926,228 13,574,292 40,429,215 24,731,540
Operating income (loss) (2,800,017) (113,717) (4,462,140) 848,779
Practice Management [Member]        
Net revenue 2,452,579 3,288,924 5,478,883 6,249,391
Direct operating costs 1,795,956 2,466,937 4,196,760 4,840,023
Selling and marketing 8,356 8,361 16,937 17,809
General and administrative 468,187 559,390 1,024,695 955,760
Research and development
Depreciation and amortization 79,497 79,077 158,993 157,830
Impairment and unoccupied lease charges    
Change in contingent consideration      
Total operating expenses 2,351,996 3,113,765 5,397,385 5,971,422
Operating income (loss) 100,583 175,159 81,498 277,969
Unallocated Corporate Expenses [Member]        
Net revenue
Direct operating costs
Selling and marketing
General and administrative 1,910,767 1,289,218 3,066,762 2,592,521
Research and development
Depreciation and amortization
Impairment and unoccupied lease charges    
Change in contingent consideration      
Total operating expenses 1,910,767 1,289,218 3,066,762 2,592,521
Operating income (loss) $ (1,910,767) $ (1,289,218) $ (3,066,762) $ (2,592,521)